Risk estimation and the prevention of cardiovascular disease

Scottish Intercollegiate Guidelines Network (2017)

SIGN - N/A

Go to publication

Evidence Categories

• Care setting: Not described
• Population group: Adults
• Population group: Pre existing health condition
• Population group: Black, Asian and Minority Ethnic populations
• Population group: General Population
• Intervention: Bupropian
• Intervention: Behaviour Support
• Intervention: Nicotine Replacement Therapy
• Intervention: Varenicline
• Intervention: Universal Smoking Cessation Interventions
• Outcome: Smoking cessation
• Outcome: Changes to smoking rates

Type of Evidence

Guidance

Overview

Cardiovascular disease (CVD) is an umbrella term that describes a range of conditions caused by blood clots (thrombosis) or build up of fatty deposits inside an artery that cause the artery to harden and narrow (atherosclerosis). The main underlying causes of CVD are coronary heart disease (CHD), stroke, peripheral arterial disease (PAD) and aortic disease. The guideline has attempted to devise effective strategies for the reduction of CVD that take a combined approach using both ‘high-risk’ and population approaches.

Recommendations

The following recommendations were highlighted by the GDG as the key clinical recommendations that should be prioritised for implementation:

2.4 Smoking. All people who smoke should be advised to stop and offered support to help facilitate this in order to minimise cardiovascular and general health risks.